- Home
- GRWG vs RLMD Comparison
GRWG vs RLMD Comparison
Compare GRWG & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRWG
- RLMD
- Stock Information
- Founded
- GRWG 2008
- RLMD 2004
- Country
- GRWG United States
- RLMD United States
- Employees
- GRWG N/A
- RLMD N/A
- Industry
- GRWG RETAIL: Building Materials
- RLMD Biotechnology: Pharmaceutical Preparations
- Sector
- GRWG Consumer Discretionary
- RLMD Health Care
- Exchange
- GRWG Nasdaq
- RLMD Nasdaq
- Market Cap
- GRWG 117.6M
- RLMD 110.6M
- IPO Year
- GRWG N/A
- RLMD N/A
- Fundamental
- Price
- GRWG $1.66
- RLMD $0.36
- Analyst Decision
- GRWG Hold
- RLMD Hold
- Analyst Count
- GRWG 5
- RLMD 4
- Target Price
- GRWG $2.75
- RLMD $4.25
- AVG Volume (30 Days)
- GRWG 633.7K
- RLMD 2.1M
- Earning Date
- GRWG 11-12-2024
- RLMD 11-07-2024
- Dividend Yield
- GRWG N/A
- RLMD N/A
- EPS Growth
- GRWG N/A
- RLMD N/A
- EPS
- GRWG N/A
- RLMD N/A
- Revenue
- GRWG $200,882,000.00
- RLMD N/A
- Revenue This Year
- GRWG N/A
- RLMD N/A
- Revenue Next Year
- GRWG N/A
- RLMD N/A
- P/E Ratio
- GRWG N/A
- RLMD N/A
- Revenue Growth
- GRWG N/A
- RLMD N/A
- 52 Week Low
- GRWG $1.55
- RLMD $0.34
- 52 Week High
- GRWG $3.38
- RLMD $7.22
- Technical
- Relative Strength Index (RSI)
- GRWG 36.93
- RLMD 17.00
- Support Level
- GRWG $1.66
- RLMD $0.34
- Resistance Level
- GRWG $1.78
- RLMD $0.40
- Average True Range (ATR)
- GRWG 0.10
- RLMD 0.09
- MACD
- GRWG -0.02
- RLMD -0.02
- Stochastic Oscillator
- GRWG 13.73
- RLMD 0.72
About GRWG GrowGeneration Corp.
GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, advanced indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.